Angiodynamics Inc. Revenue 2010–2025
Angiodynamics Inc. annual/quarterly revenue history and growth rate from 2010 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Angiodynamics Inc. revenue for the quarter ending February 28, 2026 was 78.4 M, a 8.91% increase year-over-year.
- Angiodynamics Inc. revenue for the twelve months ending February 28, 2026 was 305.6 M, a 3.73% increase year-over-year.
- Angiodynamics Inc. annual revenue for 2025 was 292.5 M, a 3.76% decrease from 2024.
- Angiodynamics Inc. annual revenue for 2024 was 303.9 M, a 10.28% decrease from 2023.
- Angiodynamics Inc. annual revenue for 2023 was 338.8 M, a 7.13% increase from 2022.
- Angiodynamics Inc. annual revenue for 2022 was 316.2 M.
Angiodynamics Inc. (ANGO) — Frequently Asked Questions
Angiodynamics Inc. (ANGO) is a publicly traded US company. It has a market capitalization of $489M. In fiscal 2025 it reported revenue of $292M and net income of -$34M. Explore ANGO's stock price, financial statements, earnings history, margins and key ratios below.
What is Angiodynamics Inc.'s market cap?
Angiodynamics Inc. (ANGO) has a market capitalization of $489M.
What is the ANGO stock price?
ANGO trades at $11.97 (-2.52% on the day).
How much revenue does Angiodynamics Inc. make?
Angiodynamics Inc. reported revenue of $292M in fiscal 2025.
Is ANGO profitable?
In fiscal 2025, Angiodynamics Inc. reported net income of -$34M.